2021-2030 Analysis and Review Biotechnology Reagent Market
Biotechnology Reagent Market By Type, By Application - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021 – 2030
The biotechnology reagents market is expected to grow with a CAGR of 9.6% during the forecast period of 2022-2030. Biotechnology reagents can be defined as chemical compound that promotes a biochemical reaction and gets consumed within the process. A diverse range of biochemical reagents are known for the identification of certain metabolomics as well as to differentiate between bacteria. For example, in gram staining crystal violet and safranin used to difference between gram-positive and gram-negative bacteria. Some of the finest examples of biotechnology reagents include Ellman’s reagent, N-Ethylmaleimide, Maltosides, 3-Azidocoumarin and so on. The global biotechnology reagent market has been driven by factors such as the growth of biotechnology pharmaceuticals, increasing R&D expenditure in the biotechnology sector and the rising number of biotechnology firms. On the other hand, high cost is restraining the growth of the industry.
Life Science Reagents: The Leading Technology
Life science reagents market gains the major revenue share of 64.8% in 2021 in global biological reagents market. The growth of this segment is backed by the growing application of biotechnology and biosciences within the pharmaceuticals and healthcare sector and the increasing prevalence of genetic disorders such as cystic fibrosis. Approx. 30,000 people are currently suffering from cystic fibrosis in the U.S. In the U.S. around 30 million individuals are living with rare diseases such as AIDS dysmorphic syndrome. Around 1 in 10 Americans or can be said 10% of the U.S. population are suffering from rare diseases. And around 80% of rare diseases are genetic in origin. Along with it, the key genetic disorder that has impacted extensively the lives of the global population is cancer. By 2025, approx. 19.3 million new cases of cancer are projected to be diagnosed which was 14.1 million in 2012. Life science reagents play a vital role in the drug development for genetic disorders due to which life science reagents have gained attraction in the pharmaceutical sector. These reagents are also employed to determine the profile of protein and lipid which has also attributed towards the growth of this segment. Supportive government initiatives such as 100% FDI via the automatic route for the manufacture of drugs in India is also expected to propel the market growth. Life science reagents segment is expected to witness a growth rate of 9.4% during 2022-2030.
Flow Cytometry: An Opportunistic Market
In biotechnology industry, flow cytometry can be described as a laser/impedance based biophysical technology deployed in cell sorting, cell counting, protein engineering and biomarker detection by suspending the cells within a stream of fluid and then passing them through an electronic detection apparatus. This technology permits simultaneous analysis of the chemical and physical characteristics of around thousands of particles in per second. The growth of this technology is backed by its constant use in the health disorders diagnosis specifically blood cancer but has also made its presence felt in various other applications including clinical practice, research and clinical trials. Flow cytometry segment is projected to witness a CAGR of 10.8% during the forecast period 2022-2030, due to availability of the high speed clinical grade cell sorters for stem cell research and clinical development coupled with automated sample preparation & handling which permits high throughput for drug discovery as well as development. Moreover, growing development of new antibody, as well as deoxo-fluors reagents that will attribute towards the technological advancements in cellular and molecular biology, is expected to fuel the market growth over the projected period. These factors create opportunities for the market players to invest in the flow cytometry segment.
North America: The key Revenue Generating Region
North America holds the largest revenue share of 47.9% in global biotechnology reagents market. The growth of the region is primarily driven by the increasing R&D expenditure and the high revenue generation from the biotechnology sector. Increasing R&D expenditure has widened the scope for the biotechnology reagents market in North America. North America biotechnology reagent market is expected to witness a growth rate of 9.3% during the forecast period 2022-2030. Moreover, the biotechnology reagent market in North America is driven by the research going on areas such as genome editing and treatment of rare diseases such as cancer and Alzheimer. CRISPR-Cas9—the revolutionary gene-editing technology—is being tested on humans. Researchers will remove T cells from cancer patients, genetically modify them, and then deliver the cells back to the patient, in an attempt to see if CRISPR is safe for use in people. The other key factors that has attributed significantly towards the growth of the North America biotechnology reagents market is the presence of high number of biotech R&D firms within the region.
Biotechnology Firms across Countries
The U.S. leads the biotechnology industry in terms of a number of biotech firms, biomedical treatment approvals, and PCT patent applications. The other countries that have been gained a position in the top 10 countries in terms of the presence of biotech firms include Korea, UK, Germany, Mexico, Japan, Belgium, and New Zealand. Small biotech firms gained the major share with approx. 72% of the biotech firms in the U.S. possessing 50 or fewer employees. The presence of highest number of biotech firms in the U.S. supports the market share of North America in the global biotechnology reagents market. European countries such as Spain, France, Germany, Italy, and UK have also secured a top ranking in terms of biotech companies attributing towards the market share of Europe in global biotechnology reagents market. Moreover, in case of Asia Pacific, Japan and Korea has attributed extensively towards the growth of the regional biotechnology reagents market.
Market Characterized by Intensive Competitive Rivalry
The market is filled with a huge number of companies, each of which is specialized into biotechnology reagents for specific purposes such as drug testing, gene expression etc. Some of the major companies involved in the biotechnology reagents market are Danaher; Thermo fisher; Beckton, Dickinson & Company, Bio-Rad, Agilent Technologies, and Abbott Laboratories. The competitive rivalry is high in the market due to the availability of a large number of companies such as Merck, Abbott. The small firms are also giving strong competition to large companies by active involvement in R & D activities and improving quality and cost. The companies are also using various strategies to expand their market share.
Historical & Forecast Period
This research report presents the analysis of each segment from 2020 to 2030 considering 2021 as the base year for the research. Compounded annual growth rate (CAGR) for each respective segment are calculated for the forecast period from 2021 to 2030.
Report Methodology
Market revenues and CAGR were derived from primary and secondary research. Both quantitative and qualitative trends were considered for extrapolation of market revenues. The derived market estimates were further validated from top down, bottom strategies and primary research. The scope of the market is limited to the following segments of product categories and region.
By Type (2020-2030; US$ Mn)
By Application (2020-2030; US$ Mn)
By Region (2020-2030; US$ Mn)
Global Impact of Covid-19 Segment (2020-2021; US$ Mn)
Key questions answered in this report
| $4,600 | |
| $6,600 | |
| $13,200 |
| Request customization |
| Get market alerts |
| Ask for regional data |
| Ask for country-specific data |
1-518-730-1569
911 Central Ave #268
Albany, NY 12206, USA
